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ABSTRACT 
Infections caused by Multi Drug Resistant (MDR) organisms cause to stand a 
worldwide pandemic. MDR bacteria are an emerging threat with limited therapeutic 
options. Without having information about these strains, morbidity and mortality due to 
infections caused by these notorious bugs cannot be reduced. Alternative antimicrobial 
agent is needed beside the antibiotics to combat against these MDR organisms. Cinnamon 
is a spice obtained from the inner bark of trees of Cinnamomum sp. Traditionally it has 
also been used for medicinal purposes. In the current work we evaluated the antimicrobial 
activity of the cinnamon extract against MDR Klebsiella pneumoniae and Enterobacter 
aggalomerans, and also compared the results with drug sensitive organisms of the same 
species. Cinnamon extract was prepared with ethanol extraction procedure. The extract 
was dried and re-dissolved in Dimethyl sulfoxide (DMSO). The prepared extract was 
tested on the organisms by using agar diffusion technique followed by determination of 
Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration 
(MBC) of the cinnamon extract. From the agar diffusion test the minimum concentration 
of cinnamon extracts needed to visualise the zone of inhibition on the Mueller Hinton 
Agar was determined to be 40 mg/ml. The MIC of the cinnamon extract was found to be 1 
mg/ml and the MBC was determined as 2 mg/ml. The results obtained from this study can 
act as the stepping stone in investigating the antimicrobial properties of cinnamon extract. 
This study could be the beginning of discovering a new antimicrobial agent against the 
MDR organisms. 
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1.1 Overview 
After the discovery of penicillin by Alexander Fleming in 1928, these antibiotics are being 
widely used for treatment against infection. However, bacteria are developing resistance 
against these antibiotics while they are being applied on them. These multi drug resistant 
(MDR) organisms are now becoming one of the major concerns throughout the world. The 
regularly prescribed antibiotics are not strong enough to kill or inhibit those organisms 
(Brown, 2007). On the other hand, MDR organisms can transfer various antibiotic 
resistant genes to the wild type organisms by Horizontal Gene Transfer (HGT) and making 
it resistant to the antibiotics (Gyles & Boerlin, 2014). MDR Escherichia coli, Klebshiella 
pneumonia, Haemophillus influenzae and other organisms spread easily from hospitals 
and can be isolated from community acquired infections (Akram, Shahid, & Khan, 2007). 
As microbes are getting stronger by developing resistance against many antibiotics, it is 
getting difficult to control them. New antibiotics are required to combat against these 
organisms. 
Use of different plant parts as medicine has been a traditional practise all over the world. 
Herbalism is now the alternative solution beside antibiotics to fight against MDR 
organisms. Plant naturally develops antimicrobial properties and so plant extracts are used 
for medicinal purpose (Khan, et al., 2013). 
Cinnamon is a spice used for cooking and also as herbal medicine. The use of cinnamon 
started from 2000BC in Egypt. In medieval time doctors started to use it as medicine in 
order to treat conditions such as coughing, arthritis and sore throats.  
1.2  Background information on Cinnamon 
Cinnamon is a dried inner bark of the plant Cinnamomum sp. The species of cinnamon 
found in the common market are Cinnamomum cassia, C. burmannii, C. loureiroi and C. 
verum. Among these species C. verum (also known as Ceylon cinnamon) is sometimes 
considered to be the true cinnamon. Leaves of cinnamon are used in tea for flavour. 
Cinnamon is a very popular culinary spice and is also used in candy, gum, incense, 
toothpaste and perfumes. 
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Domain Eukarya 
Kingdom Plantae 
Subkingdom Tracheobionta 
Superdivision Spermatophyta 
Division Magnoliophyta 
Class Magnoliopsida 
Subclass Magnoliidae 
Order Laurales 
Family Lauraceae 
Genus Cinnamomum 
Species Cinnamomum cassia, C. burmannii, C. loureiroi, C. verum, C. tamala, C. 
camphora, C. elongatum, C. mexicanum, C. montanum and C. sessilifolium. 
Table 1.1- Scientific classification of cinnamon (Plant Database, 2015). 
  
Figure 1.1- (A) Cinnamon bud; (B) Cinnamon leaves; (C) Cinnamon bark and its powder. 
(Photo Source: National Tropical Botanical Garden) 
A B 
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1.3 Medical importance of Cinnamon 
Today’s advance research has found many beneficial properties of this spice. Some of the 
beneficial properties of cinnamon are highlighted below (Leech, 2015) - 
a. Traditionally, it is used to treat coughing, arthritis and sore throats  
b. It contains antioxidants 
c. It has anti-inflammatory properties 
d. It may reduce risk of heart disease 
e. It can improve sensitivity to  insulin 
f. It lowers blood sugar level and has a powerful anti-diabetic effect 
g. It may have beneficial effects on neurodegenerative diseases 
h. It may be protective against cancer 
i. It helps fight bacterial and fungal infections 
j. It may help fight the HIV virus 
Other than the benefits, the cinnamon might have some side effects also (Cinnamon | 
NCCIH, 2011) like 
a. Might be allergic to some people. 
b. Cinnamomum cassia contains coumarin, the parent compound of warfarin, which 
prevents blood from clotting. 
c. C. cassia contains some other chemicals which might harm liver. So, it is not 
suggested for liver disease patients. 
 
1.4 History of antibiotics and bacterial resistance to it 
The early history of antibiotics suggests that people unknowingly have been using   
antibiotics in order to heal wounds and treat infections. Mould and other plant parts were 
used to the site of wounds to heal. In 1928, Sir Alexander Fleming discovered penicillin 
from the fungus Penicillium notatum which was able to kill other microorganisms 
(Diggins, 1999). This was a great discovery in the history of science. Later, the use of 
antibiotics had started significantly and during the World War II, it was a life saver which 
helped to reduce the overall number of amputations and deaths (Bradley). 
The use of antibiotics has increased day by day and more are being developed which are 
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much more efficient.  Some of the antibiotics are no more effective on the organisms as 
they are developing resistance against the antibiotics due to indiscriminate use of them. As 
a consequence, pathogens resistant to two or more antibiotics are very common and   
numbers of Multi Drug Resistant (MDR) pathogens are increasing day by day. 
1.5 Screening for the antimicrobial potential of the plant extracts 
To develop an antibiotic is not an easy task and requires much effort, time and resources. 
Investigation of the antimicrobial properties of plants provides a promising ways and 
means to look for an alternative to antibiotics. For the pathogenic MDR organisms, where 
most of the antibiotics are not effective, some other antimicrobial substance has to be used 
as an alternative. Nature provides many antimicrobial substances which are effective 
against most of the organisms including the MDR pathogens. Plants products exhibiting 
natural antimicrobial activities including eugenol, thymol, carvacrol, cinnamaldehyde, 
allyl isothiocyanate, etc. are very effective against MDR organisms individually and are 
more effective when paired with an antibiotic. In a study, thymol and carvacrol were 
found to be highly effective in reducing the resistance of Salmonella typhimurium SGI 1 
(tet A) to ampicillin, tetracycline, penicillin, bacitracin, erythromycin and novobiocin and 
resistance of Streptococcus pyogenes ermB to erythromycin. With Escherichia coli N00 
666, thymol and cinnamaldehyde were found to have a similar effect in reducing the 
minimum inhibitory concentrations (MIC) of ampicillin, tetracycline, penicillin, 
erythromycin and novobiocin. Similarly, carvacrol, thymol and cinnamaldehyde were 
effective against Staphylococcus aureus blaZ and reduced the MIC's of ampicillin, 
penicillin and bacitracin. Allyl isothiocyanate was effective in reducing the MIC of 
erythromycin when tested against S. pyogenes (Palaniappan & Holley, 2010). 
Currently, 25-50% of the pharmaceutical products are derived from plant, but they are not 
used as antimicrobials. The use of plant parts for the treatment was traditionally practiced 
with great success for a long period of time. Western medicine is trying to duplicate their 
successes. Plants are rich in a wide variety of secondary metabolites such as tannins, 
terpenoids, alkaloids, and flavonoids are known to have antimicrobial activity tested in 
vitro (Cowan, 1999). The crude ethanol extract of the powder of dried leaves of Acacia 
nilotica, dried bark of Cinnamomum zeylanicum (aka. Cinnamomum verum) and dried 
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buds of Syzygium aromaticum can be used against MDR organisms causing nosocomial 
and community acquired infections (Khan, et al., 2009). 
1.6 Study subjects 
In a study of Acute Respiratory Infection in Institute for Developing Science and Health 
Initiative (ideSHi) Laboratory, nasal swab specimens were collected from suspected 
children (age group between 0-5). It was found that the bacteria isolated from the nasal 
specimens were mostly resistant to more than one antibiotic. This finding gives us the idea 
that most of the bacterium isolated from the community acquired infections are resistant to 
any of the commonly prescribed antibiotics. In that study, out of 100 specimens two 
strains of bacteria were found to have MDR characteristics. These MDR bacteria were 
resistant to more than thirteen antibiotics, including first (Gentamycin, Tobramycin, 
Ceftriaxone, Cefixime, Ciprofloxacin, Imipenem, Meropenem and Azithromycin) and 
second line antibiotics (Amikacin, Netilmicin, Pipercillin/Tazobactam, Carbenicillin and 
Polymyxin B) according to Clinical and Laboratory Standard Institute (CLSI). Due to the 
MDR properties of the bacteria, the infections cannot be easily treated by the common 
antibiotics. Antibiogram test has to be done at first to find the antibiotic sensitivity pattern 
of the bacteria which could be beneficial for proper treatment of the patients. 
1.7 Aims and objectives 
Aim of this study was to find the antimicrobial activity of the ethanolic cinnamon extract 
on MDR bacteria isolated from the nasal swab specimens collected from acute respiratory 
infected children. At the same time, the sensitive bacterial strains of the same species were 
also studied to compare the result with MDR strains. The objectives of this study were set 
to: 
a. Ethanolic extraction of the grinded cinnamon bark; 
b. Use the extract to check the antimicrobial activity by agar diffusion method against 
MDR and sensitive strains; 
c. Find the Minimum Inhibitory Concentration (MIC) of the cinnamon extract and 
d. Find the Minimum Bactericidal Concentration (MBC) of the cinnamon extract. 
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2.1 Working laboratory 
All the works were performed in the ideSHi Laboratory, IPH Building, Mohakhali, Dhaka, 
from February 2015 to June 2015. This Laboratory has got the Biosafety Level 2 (BSL-2) 
facility. All the microbiological works were done inside Biological Safety Cabinet. 
2.2 Reference bacterial strains 
In this study, I worked with four standard clinical strains of bacteria including Multi Drug 
Resistant (MDR) Klebshiella pneumonia, MDR Enterobacter agglomerans and their 
partially resistant strains which are referred as Drug Sensitive Strain (Sen.). The sensitive 
strain of Klebshiella pneumoniae was resistant to Azithromycin and Penicillin and the 
sensitive strain of Enterobacter agglomerans was resistant to Azithromycin and 
Amoxicillin antibiotics. The strains were obtained from the preserved bacterial stock of 
collected nasal swab samples from AREI study in ideSHi Laboratory. 
2.2.1 Preparation for plating bacteria 
The referred strains were taken from the STGG (a medium containing skim milk, tryptone, 
glucose and glycerin) stock culture from -80°C. They were streaked on MacConkey 
(Mac.) and Nutrient Agar (NA) Plate and incubated overnight at 37°C for growth in an 
aerobic incubator. The bacterial colony morphology was studied carefully. Isolated single 
colony obtained from the NA was enriched in Mueller Hinton Broth (MHB) for about 2 
hours at 37°C in shaking incubator. Then they were prepared for Antibiotic Sensitivity 
Test (AST). 
2.2.2 Confirmation of the reference strains 
The strains were confirmed by several procedures. These procedures include- 
1. Gram Staining 
2. Biochemical Test 
3. Analytical Profile Index (API® 20E) 
4. Antibiotic Sensitivity Test 
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2.2.2.1 Gram Staining 
Gram staining is a differential staining method which was used to differentiate between 
Gram positive and Gram negative bacteria by their cell wall composition. Gram positive 
bacteria retain the violet colour upon staining with crystal violet dye and Gram negative 
bacteria are counter strained with safranin which appears pink under microscope. 
2.2.2.2 Biochemical Test 
Different biochemical tests were used to differentiate between closely related bacteria. 
These tests were designed to identify various metabolic properties of different bacterial 
species. In this study the following biochemical tests were used- 
1. Triple Sugar Iron (TSI) 
2. Motility Indole Urease (MIU) 
3. Citrate utilization 
2.2.2.2.1 Triple Sugar Iron (TSI) Test 
TSI Test was used to check the ability to ferment sugars and produce hydrogen sulphide. 
TSI Slant contains agar, pH sensitive dye (phenol red), 1% sucrose, 1% lactose and 0.1% 
glucose, sodium thiosulphate together with ferrous sulphate or ferrous ammonium 
sulphate. All of these ingredients were mixed together and allowed to solidify in a test 
tube in a slanted angle. This slanted shape of this medium provides an array of surfaces 
that are either exposed to oxygen-containing air in varying degrees or not exposed to air. 
Bacteria fermenting any of these three sugars will produce acid as by-products. Therefore, 
the colour of the phenol red will turn red to yellow. Position of the colour change in the 
tube will determine the fermented sugar. For example, if the butt turns yellow, it 
represents that fermentation of glucose has occurred. If the whole agar turns yellow, it 
represents that all three sugars have been fermented. If the agar turned black, it confirms 
the production of hydrogen sulphide (H2S) gas and production of bubbles confirms Carbon 
dioxide (CO2) gas formation. 
2.2.2.2.2 Motility Indole Urease (MIU) Test 
This is a multi-purpose medium used for differentiation of the enterobacteriacae. It 
combines three individual tests into a single medium- motility of the organism, indole 
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production and presence of urease enzyme. A needle with a pure culture or a discrete 
single colony of the test organism was inoculated by making a single stab into the 
medium. If the organism was motile, it would be producing a hazy area around the stabbed 
region and if non-motile then the region will be sharp. Indole production will be detected 
by the indole reagent paper attached at the top of the test tube. Positive reaction will 
change the paper colour. If the bacteria has urease enzyme, it will degrade the urea present 
in the medium into ammonia. This ammonia will react with water to produce ammonium 
hydroxide and thus the colour of the medium will turn yellow to red. 
2.2.2.2.3 Citrate Utilisation Test 
This test used to check whether the organism was able to utilise the citrate present in the 
medium as sole carbon source for energy. For this study, the citrate agar medium was 
made with Simmons Citrate Agar powder. The positive result of the citrate utilization test 
changes the colour of the medium from green to blue and there would be no colour change 
for the negative result. 
2.2.2.3 Analytical Profile Index 
The Analytical Profile Index (API) is a mini-biochemical test which was used to 
distinguish between groups of closely related bacteria for their identification. There are 20 
biochemical tests which are compiled together in a single test strip. Different test panels 
are prepared in dehydrated forms which are reconstituted upon addition of bacterial 
suspensions. The inoculated whole API® 20E test kit strips were incubated overnight at 
37°C in an aerobic incubator. After the incubation period, test results are used to construct 
a 7-digits profile. Using this profile, the identity of the bacterium was derived from the 
database with the relevant cumulative profile code book or software. 
2.2.2.4 Antibiotic Sensitivity Test 
The antibiotic sensitivity test (AST) was used to find out the sensitivity of a bacterial 
strain against different types of antibiotic. For this purpose the bacterial strains were 
enriched for 2 hours at 37°C in incubator followed by swabbing the bacterial strains on 
Mueller Hinton Agar (MHA) with a sterile swab stick so that a mat of bacteria was 
produced on the agar plate. Then with a sterile forceps an antibiotic disc was picked up 
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from the cartage and applied on the agar plate. The plate was again incubated overnight at 
37°C in an incubator. Next day the zone of inhibition (clear zone) was measured with a 
ruler and compared with the Antibiotic disc zone diameter interpretation. 
2.2.3 Preservation of bacteria 
To use the bacteria for a long period of time we needed to preserve them in a proper 
condition. We had to make sure that there were no characteristic changes in the strains. 
Accordingly, we stored the bacterial strains for short term as well as for long term 
preservation. 
2.2.3.1 Short term preservation 
For daily or weekly use of the bacteria short term preservation method was followed. 
There is a chance of the bacterial colony to get mutated when the culture is old because the 
competition for nutrition and space increases between the bacteria in the same colony. So 
the bacteria try to develop to get the most benefits. In this study, the bacteria were 
preserved for short time period in agar plates. NA and Mac. Agar plates were used for this 
purpose. A single colony of bacteria was taken in a loop and was streaked on the agar 
plates by quadrant streak method to get more single colonies. The plates were incubated 
overnight at 37°C to get the colonies. Following day, the plates were sealed with 
Parafilm® and stored at 4°C refrigerator for the next use (Thiel, 1999). The Parafilm® 
helps to avoid any contamination in the plate while storing and also it helps to maintain 
the moisture in the plate which prevents the bacterial colonies from drying. Using this 
method, the strains can be stored in the refrigerator for a month. For this study, the strains 
were sub-cultured on seventh day after culturing to maintain healthy bacterial colonies.  
2.2.3.2 Long Term Preservation 
Long term bacterial preservation is important because it helps to store the strain as stock 
sample. The bacteria could be revived again for later use if the short term preserved 
bacteria are very old with possibility of mutation. For this study, long term preservation of 
bacteria was done in a medium containing skim milk, tryptone, glucose, and glycerine 
(called STGG medium) and it was stored at -80°C in Ultra Low Temperature (ULT) 
freezer. It is an inexpensive medium and remains stable for at least 6 months after 
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sterilization (O'Brien, et al., 2001). Every 6 months the bacteria were thawed from the 
freezer, streaked on the agar plate and incubated overnight at 37°C to culture the bacteria. 
Next day, the bacterial colonies were ready for use or a few single colonies were picked up 
and inoculated in fresh STGG medium and restored in the ULT freezer for further 
preservation. 
2.3 Preparation of extract 
The cinnamon extracts were prepared by the following procedure- 
1. The cinnamon barks were washed with deionised water and dried overnight in an 
oven. 
2. The barks were then grinded using a grinder. 
3. About 25g of grinded cinnamon was taken in a beaker and 250 ml of ethanol was 
added. The beaker was then sealed with a Parafilm® and stored overnight at room 
temperature. 
4. Then the extract was filtered with a filter paper followed by filtering them with 
0.2µm filter to remove any debris of cinnamon wood from the bark. 
5. The extract was subjected to drying with vacuum dryer to remove all the ethanol 
from the extract. 
6. The dry extract was then dissolved in dimethyl sulphoxide (DMSO). 
2.4 Anti-microbial activity of cinnamon extract 
The anti-microbial activity of cinnamon extract was tested by three methods. 
1. Agar diffusion method, 
2. Minimum inhibitory concentration and 
3. Minimum bactericidal concentration 
2.4.1 Agar diffusion method 
The agar diffusion assay is a method for quantifying the capacity of anti-microbial agents 
to inhibit bacterial growth and it is the simplest one. It can be done in two ways, one is 
disk diffusion method and another is well diffusion method. In disk diffusion method, the 
disk is soaked in anti-microbial solution and dried. The dried disk is placed on microbe 
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matted agar plate. The anti-microbial agent from the disk gets diffused in the agar and 
creates a clear zone around disk. On the other hand, in well diffusion method, a hole is 
punched in the agar plate using a cork borer. A definite volume of the anti-microbial agent 
is added. To that hole the anti-microbial agent diffuses to the agar and creates a clear zone 
around the hole. If the organism is resistant to the anti-microbial agent no clear zone 
appears. 
For this study the well diffusion method was followed. MHA was used for bacterial 
culture. Bacterial culture no more than 16-20 hours old was used. The organisms were 
enriched in MHB for 2-3 hours. Using a sterile cotton swab, the enriched inoculum was 
lawned on an agar plate. Holes were punched on the inoculated agar plate with sterile 0.2 
ml micropipette tips. To those holes 50 µl of the cinnamon extract solution and control 
solution for the extract were added at different concentrations. The cinnamon extract and 
its control were diluted with 0.2 µm filtered and autoclaved deionised water to achieve 
definite concentration. After adding the cinnamon extract and control, the plate was 
incubated overnight at 37°C. 
2.4.1.1 Quality control 
It is important to set up a quality control while doing any experiment. Quality control 
helps to compare the results obtained with a positive response and a negative response to 
ensure there is no positive or negative impact on the result. 
2.4.1.1.1 Quality control for biochemical tests of the organisms. 
For all the above mentioned biochemical tests performed, a negative control was set up. 
This was done without inoculating any organism to the test tubes. This helped to verify if 
any external source (contamination) was impacting the test results. The non-inoculated test 
tube (negative control) was kept in the same condition as test organisms test tubes. After 
overnight incubation, the results were compared. The negative control should not give any 
significant reaction. 
2.4.1.1.2 Quality control for agar diffusion test 
This control was set up to check whether any other components, for example, the solvent, 
DMSO, or the diluent water have had any effect on the bacterial strains or not. The 
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amount of DMSO used to dissolve the cinnamon extract and total volume of the dissolved 
extract were recorded. The same volume of DMSO was taken in a falcon tube and total 
volume of DMSO was adjusted with 0.2 µm filtered and autoclaved deionised water. 
Control for the extract was diluted in the same way as the extract itself. Several dilutions 
of the control were also prepared for the agar diffusion test. 
2.4.1.1.3 Quality control for minimum inhibitory concentration of the cinnamon 
extract 
The quality control for the minimum inhibitory concentration of the cinnamon extract was 
setup by keeping a negative control and a positive control for the test organisms. From the 
series of dilutions of the cinnamon extract, one concentration was set to 0 mg/ml, which 
means no cinnamon extract was added to those set vials. This concentration was used as 
control. From the control set, one of the five dram vials was not inoculated, which served 
as the negative control for the experiment. To the remaining four dram vials of the control 
set, four test bacteria were inoculated to serve as the positive control of the experiment. If  
visible  growth was not observed in these vials, it could be indicative of the presence of a 
growth inhibiting factor or non-viability of the bacteria used. 
2.4.1.1.4 Quality control for minimum bactericidal concentration of the cinnamon 
extract 
The quality control for minimum bactericidal concentration was done by inoculating from 
the positive control culture medium, where no cinnamon extract was added. The purpose 
of the positive control was to ensure that there was  no other external inhibitor other than 
the cinnamon extract affecting the secondary growth of the test organism on the MHA. 
After the inoculation of the of the organisms on MHA from different concentrations of the 
cinnamon extracts, all the MHA plates were incubated overnight in a 37°C aerophilic 
incubator to observe the growth of the organisms.  
2.4.2 Minimum inhibitory concentration of cinnamon extract 
Minimum inhibitory concentration or MIC is the minimum concentration of the cinnamon 
extract required to inhibit the growth of the bacterial strains. 
 
 
Chapter 2: Methodology 
_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________  
 
Page | 15  
 
 
2.4.2.1 Preparation of broth medium with different concentrations of extract 
To find out the MIC, a set of different concentrations of cinnamon extract was prepared 
with the concentrations 8 mg/ml, 4 mg/ml, 2 mg/ml, 1 mg/ml, 0.5 mg/ml and 0 mg/ml in 
MHB. The stock extract concentration was 80 mg/ml. From the stock cinnamon extract 
concentration, 200 µl of the cinnamon extract was added to 1.8 ml of MHB to make 8 
mg/ml concentration. For preparing next concentrations, the stock extract was serially 
diluted with 0.2 µm filtered and autoclaved deionised water to make 40 mg/ml, 20 mg/ml, 
10 mg/ml, and 5 mg/ml of the concentrations of extract. From these later concentrations, 
200 µl was taken and added to 1.8 ml MHB to produce 4 mg/ml, 2 mg/ml, 1 mg/ml, and 
0.5 mg/ml concentration respectively. It was found that some precipitation had occurred 
after addition of the cinnamon extract and the mixture became cloudy. The mixture was 
mixed using vortex machine so that the anti-microbial agent got mixed with the MHB. 
Then the precipitate was centrifuged at 5000 rpm for 10 minutes. The supernatant was 
taken in a dram vial and the pellet was discarded. 
2.4.2.2 Preparation of inoculums 
The inoculums were prepared by taking a 16-24 hours culture of the organism on nutrient 
agar plate. One of the colonies was picked with a sterile loop and mixed with sterile 
normal saline. The bacterial suspension was prepared using a vortex machine. The optical 
density of the suspension was measured at 600 nm wavelength using a Spectrophotometer. 
The absorbance of light by the bacterial suspension was recorded and adjusted to 0.5 
McFarland standards. The absorbance of 0.5 McFarland standards would be between 0.8-
1.0 at 600 nm wavelength of light beam to travel a distance of 1 cm pathway. If the 0.5 
McFarland Standard was set by the absorbance between the above mentioned ranges, then 
the bacterial suspension in the cuvette may contained around 1.5 x 108 CFU. The adjusted 
bacterial suspension was then transferred to a microcentrifuge tube. From the adjusted 
bacterial suspension, 20 µl was transferred to the specific dram vial containing 2 ml of 
MHB with cinnamon extract to dilute the bacterial CFU from 105 to 106. Then they were 
incubated overnight at 37°C at 200 rpm in shaking incubator. Following day the turbidity 
of the suspension was compared with the respective control extract dilutions in a 96-
microwell plate by spectrophotometer at 600nm wavelength. 
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2.4.3 Minimum bactericidal concentration of cinnamon extract 
Minimum bactericidal concentration (MBC) was required to find out the efficiency of any 
antimicrobial agent. It indicates the minimum concentration of the antimicrobial agent 
required to kill the bacteria. It was determined after determining the MIC of the 
antimicrobial by setting up a series of dilution of antimicrobial agent followed by 
inoculation of bacteria as in determining MIC. After overnight incubation at 37°C at 200 
rpm in a shaking incubator, the cultures were sub-cultured by streaking from the solutions 
on MHA with a sterile cotton swab for bacterial growth. The streaked MHA were 
incubated overnight again in 37°C in an incubator. Next day, the bacterial growths of 
respective solutions were going to give the idea about the MBC of the extract. 
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3.1 Conformation of the strains 
The strains used for this study were confirmed using certain laboratory test. 
3.1.1 Colony Morphology on different agar plates 
The following table and the images show the colony characteristics on MacConkey and 
Nutrient Agar Plates of different strains of bacteria used in this study. 
 
Organism Agar Plate 
Bacterial colony characteristics 
Size* Margin Elevation Pigment Form Consistency 
AREI-DN-005 
(Sen. K. 
pneumoniae) 
MacConkey Small Entire Pulvinate Pink Circular Smooth 
Nutrient Large Entire Raised White Circular Smooth 
AREI-SN-014 
(Sen. E. 
agglomerans) 
MacConkey Medium Entire Pulvinate Pink Circular Mucoid 
Nutrient Large Entire Umbonate White Circular Mucoid 
AREI-SN-044 
(MDR K. 
pneumoniae) 
MacConkey Medium Entire Pulvinate Pink Circular Smooth 
Nutrient Medium Entire Convex White Circular Smooth 
AREI-SN-046 
(MDR E. 
agglomerans) 
MacConkey Small Entire Pulvinate Pink Circular Mucoid 
Nutrient Medium Entire Convex White Circular Mucoid 
Table 3.1- Colony characteristics of the strains on different agar plates 
*All the sizes of the colonies given bellow 
Large: 4.5 mm (±0.5 mm) 
Medium: 3 mm (±0.5 mm) 
Small: 2 mm (±0.5 mm) 
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Figure 3.1- Colony appearance of AREI-DN-005 (Sen. K. pneumoniae) on (A) 
MacConkey Agar Plate and (B) Nutrient Agar Plate. 
 
A
 
B
 
Figure 3.2- Colony appearance of AREI-SN-014 (Sen. E. agglomerans) on (A) 
MacConkey Agar Plate and (B) Nutrient Agar Plate. 
 
A
 
B
 
Figure 3.3- Colony appearance of AREI-SN-044 (MDR K. pneumoniae) on (A) 
MacConkey Agar Plate and (B) Nutrient Agar Plate. 
 
A
 
B
 
Figure 3.4- Colony appearance of AREI-SN-046 (MDR E. agglomerans) on (A) 
MacConkey Agar Plate and (B) Nutrient Agar Plate. 
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3.1.2 Gram’s staining result of the strains 
The following results are showing the Gram’s staining result of the strains viewed under 
microscopic oil emersion lens. 
 
 
AREI-DN-005 (Sensitive K. pneumoniae) 
Cell wall type: Gram Negative 
Shape: Rod Shaped (Bacillus) 
 
Figure 3.5- Showing microscopic view of AREI-DN-005 
(Sensitive K. pneumoniae) 
Table 3.2- Microscopic characteristics of Sensitive K. pneumoniae after Gram’s staining 
 
AREI-SN-014 (Sensitive E. agglomerans) 
Cell wall type: Gram Negative 
Shape: Rod Shaped (Bacillus) 
 
Figure 3.6- Showing microscopic view of AREI-SN-014 
(Sensitive E. agglomerans) 
Table 3.3- Microscopic characteristics of Sensitive E. agglomerans after Gram’s staining 
 
AREI-SN-044 (MDR K. pneumoniae) 
Cell wall type: Gram Negative 
Shape: Rod Shaped (Bacillus) 
 
Figure 3.7- Showing microscopic view of AREI-SN-044 
(MDR K. pneumoniae) 
Table 3.4- Microscopic characteristics of MDR K. pneumoniae after Gram’s staining 
 
AREI-SN-046 (MDR E. agglomerans) 
Cell wall type: Gram Negative 
Shape: Rod Shaped (Bacillus) 
 
Figure 3.8- Showing microscopic view of AREI-SN-046 
(MDR E. agglomerans) 
Table 3.5- Microscopic characteristics of MDR E. agglomerans after Gram’s staining 
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3.1.3 Result of biochemical tests of the strains 
3.1.3.1 Triple Sugar Iron Test 
The following table and the figure show the result of the Triple Sugar Iron (TSI) test of the 
stains. 
Organism 
Characteristics 
Butt Slant Gas Production H2S Production 
AREI-DN-005 
(Sen. K. pneumoniae) 
Acid Acid Positive Negative 
AREI-SN-014 
(Sen. E. aggalomerans) 
Acid Acid Positive Negative 
AREI-SN-044 
(MDR K. pneumoniae) 
Acid Acid Positive Negative 
AREI-SN-046 
(MDR E. aggalomerans) 
Acid Acid Positive Negative 
Table 3.6- Triple sugar iron test result of the organisms 
  
Figure 3.9- Showing the results of Triple sugar iron test of the organisms. (A) Negative 
Control, (B) MDR K. pneumoniae, (C) Sensitive K. pneumoniae, (D) MDR E. 
agglomerans and (E) Sensitive E. agglomerans 
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3.1.3.2 Motility Indole Urease Test 
The following table and the figure show the result of the Motility Indole Urease (MIU) test 
of the stains. 
Organism 
Characteristics 
Motility Indole Urease 
AREI-DN-005 
(Sen. K. pneumoniae) 
Negative Negative Positive 
AREI-SN-014 
(Sen. E. aggalomerans) 
Positive Negative Negative 
AREI-SN-044 
(MDR K. pneumoniae) 
Negative Negative Positive 
AREI-SN-046 
(MDR E. aggalomerans) 
Positive Negative Negative 
Table 3.7- MIU test result of the organisms. 
 
Figure 3.10- Showing the results of MIU test of the organisms. (A) Negative Control, (B) 
MDR K. pneumoniae, (C) Sensitive K. pneumoniae, (D) MDR E. agglomerans and (E) 
Sensitive E. agglomerans 
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3.1.3.3 Citrate Utilisation Test 
The following table and the figure show the result of the Citrate Utilisation Test of the 
stains on Simmon’s citrate agar. 
Organism Reaction 
AREI-DN-005 
(Sen. K. pneumoniae) 
Positive 
AREI-SN-014 
(Sen. E. aggalomerans) 
Positive 
AREI-SN-044 
(MDR K. pneumoniae) 
Positive 
AREI-SN-046 
(MDR E. aggalomerans) 
Positive 
Table 3.8- Citrate utilization test result of the organisms. 
  
Figure 3.11- Showing the results of citrate utilization test of the organisms. (A) Negative 
Control, (B) MDR K. pneumoniae, (C) Sensitive K. pneumoniae, (D) MDR E. 
agglomerans and (E) Sensitive E. agglomerans 
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3.1.4 Analytical Profile Index 
The following shows the result of the Analytical Profile Index of the strains used in this 
study. The result is based on several biochemical reactions of the strains in API® 20E 
strips. 
 
 
Figure 3.12- Showing API® 20E strip of AREI-DN-005 
 
 
Figure 3.13- Showing API® 20E strip of AREI-SN-014 
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Figure 3.14- Showing API® 20E strip of AREI-SN-044 
 
 
Figure 3.15- Showing API® 20E strip of AREI-SN-046 
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From the API Results we get a 7-digits profile for the tested organisms. The identity of the 
organisms used in this study were found from the database code book by using the 7-digits 
profile which are tabulated below-  
Organism Id. API® 20E Org identified. 
AREI-DN-005 1215773 Klebsiella pneumoniae 
AREI-SN-014 1205373 Enterobacter agglomerans 
AREI-SN-044 1215773 Klebsiella pneumoniae 
AREI-SN-046 1205773 Enterobacter agglomerans 
Table 3.9- Showing the identified organisms from the Analytical Profile Index results 
3.1.5 Antibiotic Sensitivity Test Results 
After overnight incubation of the organisms on Mueller Hinton agar plate with the 
antibiotic discs the results are as following 
Organism 
Id. 
First Line Antibiogram Second Line Antibiogram 
CN 
10 
TOB 
10 
CRO 
30 
CFM 
5 
CIP 
5 
IMP 
10 
MEM 
10 
AZM 
15 
AK 
30 
NET 
10 
TZP 
110 
CAR 
100 
PB 
50 
AREI-DN-005 S S S S S S S R - - - - - 
AREI-SN-014 S S S S S S S R - - - - - 
AREI-SN-044 R R R R R S S R R R R R R 
AREI-SN-046 R R R R R R R R R R R R R 
Table 3.10- Antibiotic sensitivity data of the organisms according to the Clinical and 
Laboratory Standard Institute (CLSI). 
From the Antibiotic Sensitivity Test (AST), it was found that AREI-DN-005 and AREI-
SN-014 were sensitive to most of the first line antibiotics except Azithromycin 15 µg 
(AZM-15). These organisms were referred as sensitive (Sen) organisms. As the organisms 
were sensitive to most of the first line antibiotics, their second line antibiogram was not 
done. On the other hand, AREI-SN-044 was resistant to most of the first line antibiotics 
except Imipenem and Meropenem 10 µg. The AREI-SN-046 was resistant to all of first 
line as well as second line antibiotics. Therefore, AREI-SN-044 and AREI-SN-046 are 
referred as Multi Drug Resistant (MDR) Organisms. 
3.2 Anti-microbial activity of cinnamon extract 
3.2.1 Result of agar diffusion method 
The results of anti-microbial activity of the cinnamon extract against MDR and Sen. 
Klebsiella pneumoniae and Enterobacter agglomerans are given below. 
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MDR Klebsiella pneumonia 16 11 9 - - - - - - - - - 
MDR Enterobacter agglomerans 14 9 8 - - - - - - - - - 
Sen. Klebsiella pneumoniae 16 11 9 - - - - - - - - - 
Sen. Enterobacter agglomerans 18 14 10 - - - - - - - - - 
Table 3.11- Clear zone size of the organisms with different concentrations of cinnamon 
extracts. 
 
                
Figure 3.16- Zone of inhibition of MDR Klebsiella pneumoniae with different 
concentrations of cinnamon extract. 
 
 
              
Figure 3.17- Zone of inhibition of MDR Enterobacter agglomerans with different 
concentrations of cinnamon extract. 
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Figure 3.18- Zone of inhibition of Sensitive Klebsiella pneumoniae with different 
concentrations of cinnamon extract. 
 
 
                
Figure 3.19- Zone of inhibition of Sensitive Enterobacter agglomerans with different 
concentrations of cinnamon extract. 
 
The results suggest that there was a significant effect of the cinnamon extract on inhibition 
of the growth of the above-mentioned bacteria until the minimum concentration of 40 
mg/ml was achieved to visualize a zone of inhibition on MHA. 
3.2.2 Result of Minimum Inhibitory Concentration (MIC) of the cinnamon extract on 
the organisms. 
After inoculation of the organisms in various concentrations of the cinnamon extract in 
Mueller Hinton Broth, next day the optical densities of the broth mediums were measured 
in 96-microwell plate using spectrophotometer at wavelength 600 nm. The mean optical 
densities of the broths are shown below. 
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Organisms 
Concentration of the Cinnamon Extract 
Keys 8 
m
g/
m
l 
4 
m
g/
m
l 
2 
m
g/
m
l 
1 
m
g/
m
l 
0.
5 
m
g/
m
l 
0 
m
g/
m
l 
(C
on
tr
ol
) 
Control (No Organism) 0.126 0.1 0.08 0.08 0.07 0.046 
No Growth 
Medium Growth 
Heavy Growth 
MDR Klebsiella pneumoniae 0.102 0.086 0.091 0.079 0.922 1.087 
MDR Enterobacter agglomerans 0.113 0.085 0.081 0.084 0.885 0.914 
Sen. Klebsiella pneumoniae 0.097 0.086 0.077 0.082 0.948 1.084 
Sen. Enterobacter agglomerans 0.111 0.08 0.081 0.083 0.456 0.431 
Table 3.12- The mean absorbance of the broth mediums at spectrum of 600nm 
wavelength 
The absorbance results in the Table 3.12 suggest that no significant growth of bacteria 
were observed in the concentrations 8, 4, 2 and 1 mg/ml. Therefore, the MIC of the 
cinnamon extract for all above mentioned bacteria was 1 mg/ml. 
 3.2.3 Result of Minimum Bactericidal Concentration (MBC) of the cinnamon extract 
on the organisms. 
The minimum bactericidal concentration (MBC) of the extract was done by culturing the 
organisms in different concentrations of cinnamon extracts in Mueller Hinton Broth 
medium in a shaking incubator after overnight culture of the organisms. The broth 
mediums was then streaked with a sterile cotton swab on Mueller Hinton Agar and again 
incubated overnight for the surviving bacteria to grow. The results are given bellow. 
 Organisms 
Concentration of the Cinnamon Extract 
8 
m
g/
m
l 
4 
m
g/
m
l 
2 
m
g/
m
l 
1 
m
g/
m
l 
0.
5 
m
g/
m
l 
0 
m
g/
m
l 
(C
on
tr
ol
) 
Control (No Organism) - - - - - - 
MDR Klebsiella pneumoniae - - - + + + 
MDR Enterobacter agglomerans - - - + + + 
Sen. Klebsiella pneumoniae - - - + + + 
Sen. Enterobacter agglomerans - - - + + + 
Table 3.13- Growth of the organisms after sub-culturing them from different 
concentrations of the cinnamon extracts in Mueller Hinton Broth.  
 
Chapter 3: Results  
_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
Page | 30  
 
 
 
Figure 3.20- Checking the growth of MDR Klebsiella pneumoniae for Minimum 
Bactericidal Concentration with different concentrations of cinnamon extract. 
 
 
 
 
 
 
 
Figure 3.21- Checking the growth of MDR Enterobacter agglomerans for Minimum 
Bactericidal Concentration with different concentrations of cinnamon extract. 
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Figure 3.22- Checking the growth of Sensitive Klebsiella pneumoniae for Minimum 
Bactericidal Concentration with different concentrations of cinnamon extract. 
  
 
 
 
 
 
Figure 3.23- Checking the growth of Sensitive Enterobacter agglomerans for Minimum 
Bactericidal Concentration with different concentrations of cinnamon extract. 
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Figure 3.24- Checking the growth of (A) MDR Klebsiella pneumoniae; (B) MDR 
Enterobacter agglomerans; (C) Sensitive Klebsiella pneumoniae; and (D) Sensitive 
Enterobacter agglomerans as positive control for Minimum Bactericidal Concentration 
with different concentrations of cinnamon extract. 
 
    
Although there was no growth from the concentrations 8, 4 and 2 mg/ml, growth was 
observed from 1 mg/ml broth. These results suggest that the MBC of the cinnamon extract 
for all the above mentioned bacteria was 2 mg/ml. 
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Multi Drug Resistant (MDR) organisms are emerging threat because existing antibiotics 
are not able to combat these organisms. New antibiotics need to be discovered or existing 
antibiotics have to be modified so that these can have broad spectrum activity. However,  
both the procedures are time consuming and also costly. Use of anti-microbial activity of 
natural products like different extract of plants, herbs can be an alternative option to fight 
against those microorganisms.  
The use of herbal medicine is becoming popular due to toxicity and side effects of 
allopathic medicines. This has led to sudden increase in the number of herbal drug 
manufacturing (Agarwal, 2005). Medicinal plants play a vital role for the development of 
new drugs. Besides production of synthetic drugs, the biopharma industries in Bangladesh 
like Square Pharma, ACME and others, are producing herbal medicines also. 
This study was intended to find out a substance which can be an alternative solution to 
antibiotics to combat against a broad spectrum of bacteria, especially the MDR varieties. 
Cinnamon extract was known to have some antimicrobial properties and therefore, the 
ethanolic extracts of the cinnamon were tested on the MDR Klebshiella pneumoniae, 
MDR Enterobacter agglomerans, Sensitive Klebshiella pneumoniae and Sensitive 
Enterobacter agglomerans strains. 
Cinnamon contains 0.5-2% essential oil which is very much effective against microbes. 
The cinnamon oil consists of two major antimicrobial compounds Cinnamaldehyde 
(aldehyde) and Eugenol (phenol) (Shelef, 1984). Around 85% of this essential oil consists 
of cinnemaldehyde. This compound is very effective to inhibit both Gram positive and 
Gram negative bacteria. In addition, this compound can also inhibit the growth of mould, 
fungi too (Kartik, 2011). The mechanism of bactericidal activity of cinnamaldehyde and 
eugenol are still unknown. There is evidence supporting both membrane interaction and 
inhibition of specific cellular processes or enzymes (Gill & Holley, 2004). 
The result of agar diffusion assay (Table-3.11) suggests that there is significant inhibition 
of all strains irrespective of antibiotic resistant (MDR) or sensitive bacteria for the 
concentration between 40-160 mg/ml (E1-E3) of Cinnamon extract. However, no 
significant inhibition was observed for the concentration between 5-20 mg/ml (E4-E6). 
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From Figure 3.16 to Figure 3.19, we can observe a clear zone on the agar plate 
representing the inhibitory effect of the extract. On the other hand, the negative controls 
(C1-C6) of the extracts did not produce any significant clear zone. Thus, we can say that 
dimethyl sulphoxide (DMSO) which used to re-dissolve the cinnamon extract did not have 
any significant effect on the bacteria. 
As there was a good response in agar diffusion assay, the minimum inhibitory 
concentration (MIC) of the cinnamon extract for all the organisms were determined. The 
result (Table 3.12) indicates that the MIC for all the organisms was 1 mg/ml. No growth of 
organisms was observed in the MHB medium from the concentration 8 mg/ml to 1 mg/ml 
MHB. 
Also, minimum bactericidal concentration (MBC) was determined. The result (Table 3.13) 
indicates that the MBC for all the organisms was 2 mg/ml. No bacterial growth was found 
when the cinnamon extract concentration was from 8 mg/ml to 2 mg/ml. 
From the result of this study, it was found that the crude ethanolic extract of the Cinnamon 
was very much effective against both MDR and sensitive pathogens. From other studies 
on cinnamon extract, it was learned that it is effective against broad spectrum of bacteria, 
mould and fungi too. Therefore, cinnamon extract could be one of the antimicrobial 
alternate to the antibiotics to decrease the use of antibiotics. The result of this study is 
based on in vitro test with the organisms. In vivo test with animal model has to be done 
first before implication. 
Probably, the antimicrobial effects of the cinnamon extracts were due to the combined 
effect of different antimicrobial compounds such as cinnamaldehyde, eugenol and other 
compounds present in the extract. However, it would be great if the exact antimicrobial 
compounds could be identified from the crude cinnamon extract. Accordingly, the 
compounds need to be identified and purified using high performance liquid 
chromatography (HPLC) or other high throughput technique. If the major antimicrobial 
compound is identified, the compound could be further tested in vitro using mammalian 
cell line and in vivo test using an animal model. 
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The crude ethanolic extract of cinnamon could be a source to obtain new and effective 
herbal medicine beside the antibiotics to treat infections caused by MDR organisms from 
community acquired and nosocomial infection. Beforehand, it is necessary to find out all 
the side effects of the extract and pharmaco-kinetic properties of the cinnamon extract 
before it is to be implemented. Further phytochemical analysis of the cinnamon extract 
will be helpful for isolation and characterization its active compounds. Moreover, these 
plants extract should be investigated in vivo to better understand their safety, efficacy and 
properties. 
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APPENDIX-I 
Media composition 
The composition of the media used in the present study has been given below. Unless 
otherwise mentioned, all the media were autoclaved at 121°C for 15 min. 
1. Nutrient Agar 
Ingredients Amount (g/L) 
Peptone (Himedia, India) 5.0 
Yeast Extract (Himedia, India) 2.5 
NaCl (Sigma, Germany) 5.0 
Agar (Himedia, India) 15.0 
2. Nutrient Broth / Luria-Bertani Broth 
Ingredients Amount (g/L) 
Peptone (Himedia,India) 5.0 
Yeast Extract (Himedia,India) 2.5 
NaCl (Sigma, Germany) 5.0 
3. MacConkey Agar (Difco™) 
Ingredients Amount (g/L) 
Peptone 17.0 
Proteose Peptone 3.0 
Lactose 10.0 
Bile Salts No. 3 1.5 
Sodium Chloride 5.0 
Agar 13.5 
Neutral Red 0.03 
Crystal Violet 0.001 
4. Mueller Hinton Agar (Oxoid, England) 
Ingredients Amount (g/L) 
Beef, dehydrated infusion from 300.0 
Casein hydrolysate 17.5 
Starch 1.5 
Agar (Himedia, India) 15.0 
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5. Mueller Hinton Broth (Oxoid, England) 
Ingredients Amount (g/L) 
Beef, dehydrated infusion from 300.0 
Casein hydrolysate 17.5 
Starch 1.5 
6. Triple Sugar Iron Agar (Difco™) 
Ingredients Amount (g/L) 
Beef Extract 3.0 
Yeast Extract 3.0 
Pancreatic Digest of Casein 15.0 
Proteose Peptone No. 3 5.0 
Dextrose 1.0 
Lactose 10.0 
Sucrose 10.0 
Ferrous Sulfate 0.2 
Sodium Chloride 5.0 
Sodium Thiosulphate 0.3 
Agar 12.0 
Phenol Red 0.024 
7. Motility Indole Urease Agar 
Ingredients Amount (g/L)  
NaCl (Sigma) 5 Prepare up to 900ml for 
autoclave Agar (Himedia, India) 4 
KH2PO4 (Fisher Chemical, USA) 2 
Peptone (Himedia, India) 30 
Phenol Red (0.25%) (Sigma, India) 2 ml/L 
Urea (Amresco, USA) 20 Prepare up to 100ml for filter 
sterilization 
8. Simmon's Citrate Agar (Oxoid, England) 
Ingredients Amount (g/L) 
Magnesium sulphate 0.2 
Ammonium dihydrogen phosphate 0.2 
Sodium ammonium phosphate 0.8 
Sodium citrate, tribasic 2.0 
Sodium chloride 5.0 
Bromothymol blue 0.08 
Agar 15.0 
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APPENDIX-II 
List of Antibiotics 
Name Concentration Short Form Manufacturer 
Gentamycin 10 µg/disc CN10 Oxoid 
Tobramycin 10 µg/disc TOB10 Oxoid 
Ceftriaxone 30 µg/disc CRO30 Oxoid 
Cefixime 5 µg/disc CFM5 Oxoid 
Ciprofloxacin 5 µg/disc CIP5 Oxoid 
Imipenem 10 µg/disc IMP10 Oxoid 
Meropenem 10 µg/disc MEM10 Oxoid 
Azithromycin 15 µg/disc AZM15 Oxoid 
Amikacin 30 µg/disc AK30 Oxoid 
Netilmicin 10 µg/disc NET10 Oxoid 
Pipercillin/Tazobactam 110 µg/disc TZP110 Oxoid 
Carbenicillin 100 µg/disc CB100 Oxoid 
Polymyxin B 50 units/disc PB50 Oxoid 
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APPENDIX-III 
Instruments 
The important equipments used through the study are listed below: 
Name Manufacturer 
Autoclave WiseClave 
Refrigerator Electra, Samsung (+4°C)- to store bacteria; 
Vestfrost (+4°C)- to store bacterial 
medium; 
Freeze Vestfrost (-20°C) to store stock antibiotics; 
ESCO (-80°C) to store stock bacteria. 
Incubator Memmert 
Shaking Incubator WiseCube 
Oven WiseVen 
Water bath WiseBath 
Micropipette (2-20μl)- Gilson and Costar® 
(20-200μl)- Gilson and Costar® 
(200-1000μl)- Gilson 
Bio-Safety Cabinet ESCO Class-II Type-A2 Labculture® 
Biological Safety Cabinet 
Vortex Mixture Machine WiseMix 
Weighing Machine OHAUS® 
Weighing Paper Fisherbrand® 
Vacuum Drier Savant SpeedVac® SC110 
Vacuum Pump MILLIPORE 
Spectrophotometer Eon™ BioTek® 
96-Well Plate Nunc™ 96F Microwell Plate 
Centrifuge Machine Thermo SCIENTIFIC 
Light Microscope OLYMPUS CX41 
Grinder Miyako 
 
